BFC Planning’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$740 Buy
+200
New +$750 ﹤0.01% 3230

Other funds holding FULC

BFC Planning's FULC Position: Q3 2026 in Review

BFC Planning opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 200 shares worth $740. The stake represents ﹤0.01% of the portfolio and ranks #3230 among its holdings.

97 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • BFC Planning held 200 shares of Fulcrum Therapeutics worth $740 as of Q3 2026.
  • Fulcrum Therapeutics was a new BFC Planning position in Q3 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3230 holding.
  • 97 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.